HOME >> MEDICINE >> NEWS
Other highlights in the July 20 JNCI

Other highlights in the July 20 JNCI include a study identifying HPV types that may help manage cancer risk in women with cervical abnormalities, a study examining the risk of contralateral testicular cancer, a study that looks at the association between higher urinary melatonin levels and breast cancer risk, and a study examining how accurately Medicare claims data reflect chemotherapy use in elderly beneficiaries.

Identifying HPV Types May Help Manage Cancer Risk in Women With Cervical Abnormalities

Women whose Pap test results are equivocal or mildly abnormal and who are positive for human papillomavirus (HPV) type 16 have an increased risk of developing cervical precancer compared with women diagnosed with other HPV types, according to a new study. A second study concludes that distinguishing HPV type 16 and 18 during cervical cancer screening may identify women with normal cervical cytology at greatest risk of cervical precancer and permit less aggressive management of women with other types of HPV infections.

HPV type 16--the most common and oncogenic HPV type--and HPV18 account for 60% to 70% of cervical cancer cases worldwide. Other oncogenic types of HPV are responsible for virtually all remaining cases. A pooled test for 13 types of HPV is currently being used for triage of equivocal cervical cytology results in women of any age and as an adjunct screening test with cervical cytology for women ages 30 and older. However, it was not previously known whether detection of specific HPV types would be clinically helpful in management of cervical cancer risk in women.

To determine the risk of cervical precancer in women with HPV16, Philip E. Castle, Ph.D., M.P.H., of the National Cancer Institute, and colleagues tested 5,060 women enrolled in a study, the atypical squamous cells of undetermined significance (ASCUS) low-grade squamous intraepithelial lesions (LSIL) Triage Study (ALTS), for HPV16 and other oncogeni
'"/>

Contact: Sarah Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
19-Jul-2005


Page: 1 2 3 4 5

Related medicine news :

1. Other highlights in the May 2 JNCI
2. Other highlights in the Dec. 6 JNCI
3. Other illnesses play role in difference in breast cancer survival rates between blacks and whites
4. Other highlights in the October 5 JNCI
5. Other highlights in the May 18 JNCI
6. Other highlights in the May 4 JNCI
7. Research highlights from Thoracic Society Conference
8. SCAI highlights study using wireless technology to speed care of heart attack patients
9. SCAI Founders Lecture highlights remarkable progress in catheter-based aortic valve replacement
10. Latest IPCC report highlights need for integrated climate/human behavior models
11. New report highlights aromatase inhibitor side effects

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
(Date:9/9/2017)... NEW YORK , Sept. 8, 2017 ... largest independent supplier of medical equipment, supplies, drugs, ... that it has entered into an agreement to acquire ... surgical equipment based in Holtsville, New York ... which specializes in supplying new and emerging medical practices, ...
Breaking Medicine Technology:
Cached News: